Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-04 5:34 pm Sale | 2025-02-27 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 131,269 9.990% | -84,234 (-39.09%) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-09-30 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 215,503 19.990% | 166,395 (+338.83%) | Filing History |
| 2024-03-26 4:30 pm Purchase | 2024-03-26 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 49,108 15.600% | 25,149 (+104.96%) | Filing History |
| 2024-01-30 4:05 pm Purchase | 2024-01-30 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 23,960 9.900% | 9,481 (+65.48%) | Filing History |
| 2023-03-08 5:22 pm Purchase | 2023-02-27 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 14,479 8.100% | 14,479 (New Position) | Filing History |
| 2022-12-19 06:05 am Purchase | 2022-12-08 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Cystic Fibrosis Foundation | 5,168,732 19.900% | 5,168,732 (New Position) | Filing History |